JonathanArthurColasantiMD

Assistant Prof of Medicine, Emory University Associate Medical Director, Infectious Diseases Program, Grady Health System

Dr. Colasanti is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
80 Jesse Hill Jr Dr SE
Atlanta, GA 30303
Phone+1 404-712-2289

Fax+1 404-712-2278

Emory University School of MedicineFellowship, Infectious Disease, 2012
University of Miami/Jackson Health SystemResidency, Internal Medicine, 2008 - 2011
University of Miami Leonard M. Miller School of MedicineClass of 2008

PubMed

Identifying preferred program delivery attributes for long-acting injectable cabotegravir-rilpvirine in three U.S. HIV clinics: A discrete choice experiment.
Jose I Gutierrez Jr, Elizabeth T Montgomery, Samantha E Dilworth, Moira C McNulty, Jonathan A Colasanti
Journal of Acquired Immune Deficiency Syndromes. 2025-03-13
Enhancing Hepatitis B Virus Vaccine Uptake and Immunity Through Long-Acting Antiretroviral Therapy Programmatic Synergy in the US South.
Eudiah Ochieng, Vickie Robinson, Erica Anderson, Larisa Niles-Carnes, Bradley L Smith
Open Forum Infectious Diseases. 2025-03-01
Improving Perinatal HIV Care during the COVID-19 Pandemic: Implementing a Mobile Integrated Health Program to Close the Gap.
Aditi Ramakrishnan, Madeleine Goldstein, Shakti Shetty, Martina Badell, Ameeta S Kalokhe
Journal of Acquired Immune Deficiency Syndromes. 2025-02-13

Long-Acting Injectables Work Well for People Without Viral SuppressionMarch 19th, 2025
Racial Disparities Revealed in Monkeypox Vaccination DataAugust 18th, 2022
Early Data Shows Monkeypox Disproportionately Affecting Black MenAugust 10th, 2022
Join now to see all